Neuroreceptor gene polymorphisms and olanzapine depressive symptom response in schizophrenia.
Houston
John P
JP
Adams
David H
DH
Kirkwood
Sandra C
SC
Farmen
Mark
M
Downing
AnnCatherine M
AM
Breier
Alan
A
D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001569:Benzodiazepines / Q000494:pharmacology*; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology; D004311:Double-Blind Method; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D011594:Psychometrics; D011941:Receptors, Adrenergic / Q000235:genetics; D011954:Receptors, Dopamine / Q000235:genetics; D011985:Receptors, Serotonin / Q000235:genetics; D012074:Remission Induction; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy* / Q000235:genetics
D014150:Antipsychotic Agents; D011941:Receptors, Adrenergic; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D001569:Benzodiazepines; D000077152:Olanzapine